• No#766, Tongcheng Road
    Kunshan, Jiangsu Province,China

  • 86-21-2024 2659

  • Get A Quote

        Search:        

Building Block banner
  • Building Block

    Welcome to PHARMACORE CO.,LIMITED

    　　
    PharmaCore provides custom synthesis and contract research of both catalog and non-catalog building blocks.
     
    With high quality and competitive price.
     
    Offering you the first-rate service and high-efficiency business.
     
    Air freight service: door to door services.

  • 5-(Methylsulfonyl)nicotinic Acid

    1805039375-(Methylsulfonyl)nicotinic Acid

  • 2-(Methylsulfonyl)-4-pyridinecarboxylic acid

    1805039382-(Methylsulfonyl)-4-pyridinecarboxylic acid

  • 7-Aminodesacetoxycephalosporanic acid pivalamide

    1805039397-Aminodesacetoxycephalosporanic acid pivalamide

  • (E)-4-bromo-3-(2-chloro-phenoxy)-but-2-enoic acid ethyl ester

    180503940(E)-4-bromo-3-(2-chloro-phenoxy)-but-2-enoic acid ethyl ester

  • 3-Bromo-5-fluorobenzonitrile

    1805039413-Bromo-5-fluorobenzonitrile

  • (2R,3S,4R,5S)-1-(6-ethoxyhexyl)-2-methylpiperidine-3,4,5-triol

    180503942(2R,3S,4R,5S)-1-(6-ethoxyhexyl)-2-methylpiperidine-3,4,5-triol

  • 4-Bromo-1,3-benzenedicarbonitrile

    1805039434-Bromo-1,3-benzenedicarbonitrile

  • 2-Methyl-2-(4-sulfamoylphenyl)propionic Acid

    1805039442-Methyl-2-(4-sulfamoylphenyl)propionic Acid

  • (S)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid

    180503945(S)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid

  • (Tetrahydro-2H-pyran-4-yl)hydrazine

    180503946(Tetrahydro-2H-pyran-4-yl)hydrazine

  • 2-Difluoromethyl-nicotinic acid

    1805039472-Difluoromethyl-nicotinic acid

  • N-methoxy-N-methyltetrahydro-2H-pyran-4-carboxamide

    180503948N-methoxy-N-methyltetrahydro-2H-pyran-4-carboxamide

First Previous Page 324 325 326 327 328 329 330 331 332 333 334 Next Page Last Page Total 3470Page41636 Record

Copyright @ PHARMACORE CO.,LIMITED. Our products are listed related to patents, for research purposes only, no commercial sales.

Back to the top